Evidence map›Paper›PMID 29843056›Full record

ReviewCurrent opinion in pharmacology2018

Mast cell activators as novel immune regulators.

Brandi Johnson-Weaver, Hae Woong Choi, Soman N Abraham, Herman F Staats

Abstract readReview
In one paragraph

Review in Current opinion in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Advancements in the Application of scRNA-Seq in Breast Research: A Review.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Impaired Proliferation of CD8Journal of immunology research · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Autophagy and Its Lineage-Specific Roles in the Hematopoietic System.Oxidative medicine and cellular longevity · 2023
    Review
  13. Article
  14. Review
  15. Review
  16. The Mast Cell-SCF-CB1 Interaction Is a Key Player in Seborrheic Keratosis.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Article
  17. Review
  18. Review
  19. Article
  20. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin BJournal of immunology (Baltimore, Md. : 1950) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Brandi Johnson-WeaverDepartments of Pathology Duke University School of Medicine, Durham, NC, 27710, United States.
Hae Woong ChoiDepartments of Pathology Duke University School of Medicine, Durham, NC, 27710, United States.
Soman N AbrahamDepartments of Pathology Duke University School of Medicine, Durham, NC, 27710, United States; Departments of Immunology Duke University School of Medicine, Durham, NC, 27710, United States; Departments of Molecular Genetics and Microbiology Duke University School of Medicine, Durham, NC, 27710, United States.
Herman F StaatsDepartments of Pathology Duke University School of Medicine, Durham, NC, 27710, United States; Departments of Immunology Duke University School of Medicine, Durham, NC, 27710, United States; Departments of Medicine, Duke University School of Medicine, Durham, NC, 27710, United States. Electronic address: herman.staats@duke.edu.

Funding

Development of Efficacious and Stable Nasal Vaccine FormulationsU01AI082107 · NIAID · DUKE UNIVERSITY · PI STAATS, HERMAN F · 2009 to 2013
$3.8M
NIAID NIH HHS HHSN272201400054CNIAID NIH HHS U01 AI082107
6 · The paper itself

Abstract

Mast cells are an important cell type of the innate immune system that when activated, play a crucial role in generating protective innate host responses after bacterial and viral infection. Additionally, activated mast cells influence lymph node composition to regulate the induction of adaptive immune responses. The recognition that mast cells play a beneficial role in host responses to microbial infection and induction of adaptive immunity has provided the rationale to evaluate mast cell activators for use as antimicrobials or vaccine adjuvants. This review summarizes the role of mast cell activators in antimicrobial responses while also discussing the use of different classes of mast cell activators as potent vaccine adjuvants that enhance the induction of protective immune responses.

Indexed as

Adaptive ImmunityAdjuvants, ImmunologicAnimalsAntigen PresentationAnti-Infective AgentsBacterial InfectionsHumansImmunity, InnateImmunologic FactorsImmunomodulationMast CellsModels, AnimalAdjuvants, ImmunologicAnti-Infective AgentsImmunologic Factors

Identifiers

PMID29843056
PMCPMC6448149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.